Literature DB >> 11180533

The development of a staggered parallel separation liquid chromatography/tandem mass spectrometry system with on-line extraction for high-throughout screening of drug candidates in biological fluids.

J T Wu1.   

Abstract

A new parallel liquid chromatography/tandem mass spectrometry (LC/MS/MS) system has been developed, in which the mass detector was shared between two staggered parallel chromatographic runs. Since the chromatography for biofluids assay generally requires good analyte retention and thus tends to leave large blank chromatographic windows, this parallel system allowed the efficient use of the mass detector during these blank windows, resulting in significantly improved sample throughput. Also, in order to remove the bottleneck in sample extraction for this parallel separation system, a high-flow extraction device was used to perform on-line extraction. This allowed for the direct injection of biofluids onto the system. The performance and capability of this system was evaluated in tests that contained a single analyte (oxazepam) and multiple analytes (12-in-1). The results indicated that the data generated from this system were comparable to those obtained on a conventional single-column system. An application of the system for high-throughput pharmacokinetic screening of drug candidates was also demonstrated. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11180533     DOI: 10.1002/1097-0231(20010130)15:2<73::AID-RCM193>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  3 in total

1.  Application of parallel liquid chromatography/mass spectrometry for high throughput microsomal stability screening of compound libraries.

Authors:  Rongda Xu; Csaba Nemes; Kelly M Jenkins; Robyn A Rourick; Daniel B Kassel; Charles Z C Liu
Journal:  J Am Soc Mass Spectrom       Date:  2002-02       Impact factor: 3.109

2.  LC-MS/MS in the Clinical Laboratory - Where to From Here?

Authors:  Stefan Kg Grebe; Ravinder J Singh
Journal:  Clin Biochem Rev       Date:  2011-02

3.  Comment on: Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance.

Authors:  David C Simpson
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.